Showing results (31-40 of 56) with videos related to
Sort By:
Pageof 6
International Journal of Pancreatology : Official Journal of the International Association of Pancreatology|February 1, 1995
Administration of a nitric oxide synthase inhibitor does not suppress low-dose streptozotocin-induced diabetes in miceG Papaccio, V Esposito, M V Latronico, et al.Bollettino Della Societa Italiana Di Biologia Sperimentale|September 15, 1981
[In vivo effects of rapid glycemic variations on HbA1c]S Frascatore, F A Pisanti, G Papaccio, et al.Journal of Cellular Biochemistry. Supplement|July 17, 2001
Tacrolimus, but not cyclosporine A, significantly increases expression of ICAM-1 and IFN-gamma in the NOD mouseG Papaccio, M V Latronico, A Graziano, et al.Endocrinology|April 4, 2000
Prevention of spontaneous autoimmune diabetes in NOD mice by transferring in vitro antigen-pulsed syngeneic dendritic cellsG Papaccio, F Nicoletti, F A Pisanti, et al.Chirurgia Italiana|February 1, 1985
[Treatment and prevention of postmastectomy lymphedema (our experience)]S Modena, F Abrescia, A Schönsberg, et al.Autoimmunity|May 16, 1998
Adhesion molecules and microvascular changes in the nonobese diabetic (NOD) mouse pancreas. An NO-inhibitor (L-NAME) is unable to block adhesion inflammation-induced activationG Papaccio, M V Latronico, F A Pisanti, et al.Microscopy Research and Technique|June 1, 1996
The harderian gland in autoimmune diabetes of the nonobese diabetic mouseG Papaccio, S Sellitti, G Salvatore, et al.La Radiologia Medica|June 1, 1994
[The role of stereotactic radiography in nonpalpable breast lesions. The authors' own experience]A Bruscagnin, E Boscolo, F Brusatin, et al.Pancreas|November 1, 1991
Further morphological and biochemical observations on early low dose streptozocin diabetes in miceG Papaccio, T Linn, K Federlin, et al.Life Sciences|January 1, 1995
Superoxide dismutase in the nonobese diabetic (NOD) mouse: a dynamic time-course studyG Papaccio, S Frascatore, F A Pisanti, et al.Pageof 6